- Fee assured
- Verified this account
- Video and telephone consultations
Dr Woolf is a graduate of the University of Birmingham. Core medical and Clinical Oncology training was in London (University College Hospital, The Royal Free and St Bartholomews’). A Master’s Degree in Oncology at the Institute of Cancer Research and a Doctorate of Medicine after research at Mount Vernon Cancer Centre.
Dr Woolf has a particular interest in the development of high quality health care participating as a member of the Keogh Quality of Care Review Inspections Panel and as Clinical Expert in Care Quality Commission (CQC) inspections.
During his career Dr Woolf has had over 20 publications in peer reviewed journals and published book chapters as well as over 40 oral and poster presentations to national and international conferences. These include multiple publications and presentations in the field of breast and lung cancer.
Dr Woolf also runs regular teaching sessions for junior doctors. He examines on The Christie FRCR examination course and has worked extensively with the Royal College of Radiologists to enhance training for clinical oncologists.
Dr Woolf plans and delivers radiotherapy at The Christie to patients with breast and lung cancers and also gives Stereotactic Ablative Radiotherapy (SABR) for lung cancers and oligometastases (cancers that have spread to the lungs). In addition he gives hormone therapy (endocrine therapy), chemotherapy and targeted drugs.
Reference number 6101982
Information for healthcare professionals (Bupa patients only, last 12 months)
Stereotactic radiotherapy (SRT), second to fifth sessions, including adjustments, using Cyberknife or similar SRT technology - (5-50)
Clinical supervision of the planning of stereotactic radiosurgery e.g. SRT/SBRT and Gamma Knife - (5-50)
Stereotactic radiotherapy (SRT), first/sole session using Cyberknife or similar SRT technology - (5-50)
Clinical supervision and planning for delivery of chemotherapy cycle 1 - 21 days - (1-5)
Clinical supervision of external beam radiotherapy, for 16 or up to and including 30 fractions - (1-5)
- Show All (9)...